KIRKLAND, Wash., Feb. 12, 2016 -- Underscoring its commitment to serving the rapidly-growing Chinese market for domain names, Rightside® (Nasdaq:NAME) today announced its expanded operations in China by establishing a Wholly Foreign-Owned Enterprise (WFOE). The news comes on the heels of Rightside seeing almost 90,000 domains registered in the Chinese market, with .LIVE, .NEWS, and .PUB being the most popular. By working with the Ministry of Industry and Information Technology (MIIT) and local partners, Rightside expects its top-level domains (TLDs) to be licensed in China in 2016.
There are currently 5.4 million new TLDs registered in China, which represents 45 percent of all new TLD registrations. By comparison, the United States is next at 1.5 million registrations. There is an enormous global market opportunity for brands and individuals to connect with their audience all over the world, leveraging domains.
“China is a rapidly expanding tech market with millions of people looking to build and enhance their online presence,” said Taryn Naidu, Rightside’s CEO. “The SEO, call-to-action, and branding benefits of domains are global and Rightside’s portfolio of TLDs is the perfect offering for businesses and consumers looking to brand themselves with shorter, more memorable web addresses.”
Well-known brands have started to embrace top-level domains like Alibaba, Apple, BMW, Google, Johnson & Johnson, Microsoft, Tencent (QQ) and more. Worldwide trends in social media, local search, and live streaming are also driving demands for many of Rightside’s most popular domains.
“We have forged strong working partnerships with seven Chinese registrars and we are looking to increase our distribution footprint. By going through the official channels, we know that brands and individuals will soon be able to realize the benefits of our domain extensions and put these websites to work in China,” said Jeff Eckhaus, SVP of market development and policy at Rightside.
Rightside’s portfolio of 39 complementary domain names provides businesses and individuals a powerful way to strengthen their brands and engage with their audience.
About Rightside
Rightside® inspires and delivers new possibilities for consumers and businesses to define and present themselves online. The company, with its affiliates, is a leading provider of domain name services, offering one of the industry’s most comprehensive platforms for the discovery, registration, usage, and monetization of domain names. In addition to being a new gTLD registry operator, Rightside is home to some of the most admired brands in the industry, including eNom and Name.com. Headquartered in Kirkland, WA, Rightside has offices in North America, Europe, and Australia. For more information please visit www.rightside.co.
Contact Acacia Krebs Director, Corporate Communications Rightside [email protected]


Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
FDA Approves Mitapivat for Anemia in Thalassemia Patients 



